Defymed's mission is to develop innovative medical devices for diabetic patients providing effective treatments and improving quality of life
million diabetics worldwide forecasted for 2045
billion per year spent on diabetes-related expenses
more than 10
million diabetics receiving insulin therapy have poorly regulated blood glucose levels
January 28 2019
Berlin, February 20-23th 2019: Defymed will participate to the 12th International ATTD (Advanced Tec...
December 07 2018
Mulhouse, December 3rd 2018: We are very proud to announce that Defymed is the winner of the Grand E...